Novo Holdings A/S

Q3 2026 13F-HR Holdings

Location
Hellerup, G7
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
27
Total value ($000)
$1,489,688
Net value change ($000)
-232,529 (-13.5%)
New positions
3
Sold out positions
1
Turnover %
8.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OBSIDIAN THERAPEUTICS INC 42,892 NEW
CRM 28,667 46.5%
SRRK 22,227 NEW
INSM 19,593 152.2%
BN 13,261 8.9%
CTNM 9,448 NEW
BABA 2,975 12.0%
DYN 840 3.9%
Top Reduces (Value $000, Stocks/ETFs)
MPLT -110,866 -83.9%
CRNX -49,394 -100.0%
MIRM -35,539 -27.0%
AVALYN PHARMACEUTICALS INC -29,571 -23.1%
HEMAB THERAPEUTICS HLDGS INC -24,624 -16.0%
ALMS -21,716 -70.2%
ASML -16,878 -8.9%
AVBP -16,531 -31.7%
PHVS -16,076 -33.2%
FND -10,799 -22.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type